These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 30716275)
1. Synthesis of ( R)-Boc-2-methylproline via a Memory of Chirality Cyclization. Application to the Synthesis of Veliparib, a Poly(ADP-ribose) Polymerase Inhibitor. Kolaczkowski L; Barkalow J; Barnes DM; Haight A; Pritts W; Schellinger A J Org Chem; 2019 Apr; 84(8):4837-4845. PubMed ID: 30716275 [TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of 2-(4,5,6,7-tetrahydrothienopyridin-2-yl)-benzoimidazole carboxamides as novel orally efficacious Poly(ADP-ribose)polymerase (PARP) inhibitors. Chen X; Huan X; Liu Q; Wang Y; He Q; Tan C; Chen Y; Ding J; Xu Y; Miao Z; Yang C Eur J Med Chem; 2018 Feb; 145():389-403. PubMed ID: 29335205 [TBL] [Abstract][Full Text] [Related]
3. Contrasting sirtuin and poly(ADP-ribose)polymerase activities of selected 2,4,6-trisubstituted benzimidazoles. Yeong KY; Tan SC; Mai CW; Leong CO; Chung FF; Lee YK; Chee CF; Abdul Rahman N Chem Biol Drug Des; 2018 Jan; 91(1):213-219. PubMed ID: 28719017 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and anticancer activities of novel dual poly(ADP-ribose) polymerase-1/histone deacetylase-1 inhibitors. Tian Y; Xie Z; Liao C Bioorg Med Chem Lett; 2020 Apr; 30(8):127036. PubMed ID: 32088129 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and Evaluation of a Mitochondria-Targeting Poly(ADP-ribose) Polymerase-1 Inhibitor. Krainz T; Lamade AM; Du L; Maskrey TS; Calderon MJ; Watkins SC; Epperly MW; Greenberger JS; Bayır H; Wipf P; Clark RSB ACS Chem Biol; 2018 Oct; 13(10):2868-2879. PubMed ID: 30184433 [TBL] [Abstract][Full Text] [Related]
6. Discovery and SAR study of 2-(1-propylpiperidin-4-yl)-3H-imidazo[4,5-c]pyridine-7-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase-1 (PARP-1) for the treatment of cancer. Zhu Q; Wang X; Hu Y; He X; Gong G; Xu Y Bioorg Med Chem; 2015 Oct; 23(20):6551-9. PubMed ID: 26422786 [TBL] [Abstract][Full Text] [Related]
7. Structural Requirements of Some 2-(1-Propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide Derivatives as Poly (ADP-Ribose) Polymerase (PARP) for the Treatment of Cancer: QSAR Approach. Sharma MC Interdiscip Sci; 2016 Mar; 8(1):11-22. PubMed ID: 26205198 [TBL] [Abstract][Full Text] [Related]
8. 1-Oxo-3,4-dihydroisoquinoline-4-carboxamides as novel druglike inhibitors of poly(ADP-ribose) polymerase (PARP) with favourable ADME characteristics. Safrygin A; Zhmurov P; Dar'in D; Silonov S; Kasatkina M; Zonis Y; Gureev M; Krasavin M J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1968-1983. PubMed ID: 34482781 [TBL] [Abstract][Full Text] [Related]
9. Discovery of the PARP (poly ADP-ribose polymerase) inhibitor 2-(1-(4,4-difluorocyclohexyl)piperidin-4-yl)-1H-benzo[d]imidazole-4-carboxamide for the treatment of cancer. Tang L; Wu W; Zhang C; Shi Z; Chen D; Zhai X; Jiang Y Bioorg Chem; 2021 Sep; 114():105026. PubMed ID: 34186467 [TBL] [Abstract][Full Text] [Related]
10. Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors. Thorsell AG; Ekblad T; Karlberg T; Löw M; Pinto AF; Trésaugues L; Moche M; Cohen MS; Schüler H J Med Chem; 2017 Feb; 60(4):1262-1271. PubMed ID: 28001384 [TBL] [Abstract][Full Text] [Related]
11. Synergistic cytotoxicity of the poly (ADP-ribose) polymerase inhibitor ABT-888 and temozolomide in dual-drug targeted magnetic nanoparticles. Muñoz-Gámez JA; López Viota J; Barrientos A; Carazo Á; Sanjuán-Nuñez L; Quiles-Perez R; Muñoz-de-Rueda P; Delgado Á; Ruiz-Extremera Á; Salmerón J Liver Int; 2015 Apr; 35(4):1430-41. PubMed ID: 24821649 [TBL] [Abstract][Full Text] [Related]
12. Veliparib: a new therapeutic option in ovarian cancer? Ghisoni E; Giannone G; Tuninetti V; Genta S; Scotto G; Aglietta M; Sangiolo D; Mittica G; Valabrega G Future Oncol; 2019 Jun; 15(17):1975-1987. PubMed ID: 31074636 [TBL] [Abstract][Full Text] [Related]
13. Discovery of 2-(1-(3-(4-Chloroxyphenyl)-3-oxo- propyl)pyrrolidine-3-yl)-1 Min R; Wu W; Wang M; Tang L; Chen D; Zhao H; Zhang C; Jiang Y Molecules; 2019 May; 24(10):. PubMed ID: 31108884 [TBL] [Abstract][Full Text] [Related]
14. Structure-based design, synthesis, and evaluation of inhibitors with high selectivity for PARP-1 over PARP-2. Yu J; Luo L; Hu T; Cui Y; Sun X; Gou W; Hou W; Li Y; Sun T Eur J Med Chem; 2022 Jan; 227():113898. PubMed ID: 34656898 [TBL] [Abstract][Full Text] [Related]
15. Novel tricyclic poly (ADP-ribose) polymerase-1/2 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis and biological evaluation. Li H; Hu Y; Wang X; He G; Xu Y; Zhu Q Bioorg Med Chem; 2016 Oct; 24(19):4731-4740. PubMed ID: 27561983 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, Cytotoxicity, and Mechanistic Investigation of Platinum(IV) Anticancer Complexes Conjugated with Poly(ADP-ribose) Polymerase Inhibitors. Xu Z; Li C; Zhou Q; Deng Z; Tong Z; Tse MK; Zhu G Inorg Chem; 2019 Dec; 58(23):16279-16291. PubMed ID: 31738050 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of Some Benzimidazole-derived Molecules and their Effects on PARP-1 Activity and MDA-MB-231, MDA-MB-436, MDA-MB-468 Breast Cancer Cell Viability. Gurkan-Alp AS; Alp M; Karabay AZ; Koc A; Buyukbingol E Anticancer Agents Med Chem; 2020; 20(14):1728-1738. PubMed ID: 32357823 [TBL] [Abstract][Full Text] [Related]
19. Poly (ADP-Ribose) Polymerases (PARPs) and PARP Inhibitor-Targeted Therapeutics. Li N; Wang Y; Deng W; Lin SH Anticancer Agents Med Chem; 2019; 19(2):206-212. PubMed ID: 30417796 [TBL] [Abstract][Full Text] [Related]
20. Identification of novel PARP-1 inhibitors: Drug design, synthesis and biological evaluation. Xie Z; Zhou Y; Zhao W; Jiao H; Chen Y; Yang Y; Li Z Bioorg Med Chem Lett; 2015 Oct; 25(20):4557-61. PubMed ID: 26342868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]